Volume 42, Issue 3 pp. 530-538
ORIGINAL ARTICLE

Radiation treatment of soft palate squamous cell carcinoma

Cooper T. Rapp MD

Cooper T. Rapp MD

Department of Radiation Oncology, University of Florida, Gainesville, Florida

Search for more papers by this author
Bhishamjit S. Chera MD

Bhishamjit S. Chera MD

Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina

Search for more papers by this author
Christopher G. Morris MS

Christopher G. Morris MS

Department of Radiation Oncology, University of Florida, Gainesville, Florida

Search for more papers by this author
Robert J. Amdur MD

Robert J. Amdur MD

Department of Radiation Oncology, University of Florida, Gainesville, Florida

Search for more papers by this author
Jessica M. Kirwan MA

Jessica M. Kirwan MA

Department of Radiation Oncology, University of Florida, Gainesville, Florida

Search for more papers by this author
William M. Mendenhall MD

Corresponding Author

William M. Mendenhall MD

Department of Radiation Oncology, University of Florida, Gainesville, Florida

Correspondence

William M. Mendenhall, Department of Radiation Oncology, University of Florida, 2000 SW Archer Rd., PO Box 100385, Gainesville, FL 32610-0385.

Email: [email protected]

Search for more papers by this author
First published: 27 November 2019
Citations: 8
Section Editor: Michael Samuels

Abstract

Background

To report our institution's experience treating soft palate squamous cell carcinoma with radiotherapy alone or combined with adjuvant chemotherapy and/or neck dissection for residual disease.

Methods

We analyzed 159 patients treated curatively between 1963 and 2016. Median follow-up was 4 years.

Results

The 5-year local control rates were T1, 90%; T2, 90%; T3, 70%; and T4, 59%. The 5-year cause-specific survival (CSS) rate was nearly identical for patients with stage I-III disease (88%, 86%, and 88%, respectively) compared to stage IVA/B (58%). Five-year overall survival was similar between patients with stage I-III disease (50%, 57%, and 54%, respectively) and approximately double that of patients with stage IVA/B disease (26%). Thirteen patients (8%) had severe complications related to radiotherapy.

Conclusions

The likelihood of cure after definitive radiotherapy is relatively high in patients with stage I-III disease with soft palate carcinoma. Patients with stage IVA/B disease have a lower cure rate but with a 5-year CSS exceeding 50%.

CONFLICT OF INTEREST

The authors declare no potential conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.